MedTrace Logo

Hepatitis B Virus Prevalence and Risk Factors in Belgium

NCT03425513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1131

Last updated 2020-01-27

No results posted yet for this study

Summary

The aim of this study was to evaluate the current prevalence and risk factors of hepatitis B virus (HBV) infection in a multi-ethnic neighbourhood situated in Middle Limburg, Belgium. Additionally, the investigators will determine linkage of care in hepatitis B surface antigen (HBsAg) positive subjects.

Conditions

Interventions

DIAGNOSTIC_TEST

Hepatitis B serology

A serum specimen will be taken and assessed for hepatitis B serology (HBsAg and anti-HBc antibodies).

OTHER

Questionnaire

Participants will be asked to fill in a questionnaire regarding demographic characteristics, known viral hepatitis status and risk factors for HBV infection.

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Principal Investigators

  • Geert Robaeys, M.D., Ph.D. · Hasselt University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-12
Primary Completion
2017-11-27
Completion
2017-11-27

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03425513 on ClinicalTrials.gov